Terminated NA INTERVENTIONAL 2-arm NCT02677311

GnRHA Therapy and Ovarian Preservation in Pediatric Cancer Patient

Gonadotropin Releasing Hormone Agonist (GnRHa) Therapy and Ovarian Preservation in Pediatric and Adolescent Subject Receiving Chemoradiation Therap

Sponsor: University of Kentucky

Conditions Cancer Chemoradiation

Interventions Blood draw Pelvic Ultrasound

Updated 7 times since 2017 Last updated: Oct 24, 2017 Started: Sep 30, 2015 Primary completion: May 31, 2017 Completion: May 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Unable to recruit required numbers for study.

Other terminated trials from University of Kentucky

See all terminations from University of Kentucky

Other Cancer trials with similar outcome

Browse all Cancer trials

This NA trial investigates Cancer and Chemoradiation and is currently terminated or withdrawn. University of Kentucky leads this study, which shows 7 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Nov 2017 — Jun 2018 [monthly]

Terminated NA

▶ Show 2 earlier versions

Jun 2017 — Nov 2017 [monthly]

Terminated NA

Status: Active Not Recruiting → Terminated
Jan 2017 — Jun 2017 [monthly]

Active Not Recruiting NA

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Kentucky

Data source: University of Kentucky

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.